Home › Funds › Cannell & Spears LLC › ABBV

Cannell & Spears LLC position in ABBV

ABBVIE INC · Health Care

Cannell & Spears LLC reported holding 244,118 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$63.9M, representing 1.17% of its reported portfolio and ranking #23 among its reported holdings. Cannell & Spears LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)244.12K sh
Reported value held$63.86M
Portfolio Weight1.17%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cannell & Spears LLC's ABBV position evolved

Cannell & Spears LLC first disclosed a stake in ABBV in Q3 2023 at 7,117 shares (US$1.1M). The position peaked in Q3 2025 at 285,026 shares, worth US$66.0M. Across 13 filings, Cannell & Spears LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 244,118 shares valued at US$63.9M — a reduction of -11,859 shares quarter over quarter.. Notable position changes include a 3722% increase in Q1 2024 (shares fell 5% over the following quarter), a 30% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.12K $1.06M New
Q4 2023 7.12K $1.10M Hold
Q1 2024 272.02K $49.54M Add
Q2 2024 270.39K $46.38M Reduce
Q3 2024 223.81K $44.20M Reduce
Q4 2024 222.48K $39.54M Reduce
Q1 2025 261.62K $54.82M Add
Q2 2025 340.43K $63.19M Add
Q3 2025 285.03K $65.99M Reduce
Q4 2025 269.63K $61.61M Reduce
Q1 2026 248.68K $54.09M Reduce
Q2 2026 255.98K $64.41M Add
Q3 2026 244.12K $63.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Cannell & Spears LLC held ABBV?

Cannell & Spears LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cannell & Spears LLC's current position in ABBV?

As of Q3 2026, Cannell & Spears LLC holds 244.12K shares of ABBV (ABBVIE INC), valued at $63.86M, representing 1.17% of its reported portfolio and ranking #23.

Has Cannell & Spears LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Cannell & Spears LLC reduced its position in ABBV. The position peaked in Q3 2025 at 285.03K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.